Related references
Note: Only part of the references are listed.Use of metformin and survival of patients with high-grade glioma
Corinna Seliger et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
D. Dong et al.
ANNALS OF ONCOLOGY (2019)
C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling
Hong-Wei Fan et al.
CELL PROLIFERATION (2019)
Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors
Marta Giussani et al.
CELLS (2019)
MicroRNA-1197 downregulation inhibits proliferation and migration in human non-small cell lung cancer cells by upregulating HOXC11
Bo Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions
Sevgen Onder et al.
CYTOPATHOLOGY (2019)
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide
Michael Dworkin et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Transcortical insular glioma resection: clinical outcome and predictors
N. U. Farrukh Hameed et al.
JOURNAL OF NEUROSURGERY (2019)
'MCC' protein interacts with E-cadherin and β-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells
F. A. Benthani et al.
ONCOGENE (2018)
Innate immune receptors drive dengue virus immune activation and disease
Joris Sprokholt et al.
FUTURE VIROLOGY (2018)
Glioma infiltration and extracellular matrix: key players and modulators
Valeria Pereira Ferrer et al.
GLIA (2018)
Adaptive adhesion systems mediate glioma cell invasion in complex environments
Pavlo G. Gritsenko et al.
JOURNAL OF CELL SCIENCE (2018)
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
Hideaki Abe et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
Sabine Hombach-Klonisch et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Nomograms are key decision-making tools in prostate cancer radiation therapy
Sarah Caulfield et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
Shuang Dai et al.
FRONTIERS IN PHARMACOLOGY (2018)
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
Zenghui Qian et al.
ONCOIMMUNOLOGY (2018)
Impact of resection on overall survival of recurrent Glioblastoma in elderly it patients
Jasmin Hager et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis
Xiaoqi Zhang et al.
ONCOTARGETS AND THERAPY (2018)
Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas
Michael D. Caponegro et al.
Oncotarget (2018)
Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives
Drazen Raucher et al.
FRONTIERS IN ONCOLOGY (2018)
Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients
Wei-Zhen Gao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Robert L. Bowman et al.
NEURO-ONCOLOGY (2017)
The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme
Dimitry A. Chistiakov et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
David Capper et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Glioma Subclassifications and Their Clinical Significance
Ricky Chen et al.
NEUROTHERAPEUTICS (2017)
CLEC5A is a critical receptor in innate immunity against Listeria infection
Szu-Ting Chen et al.
NATURE COMMUNICATIONS (2017)
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M
Michael Karsy et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Survival in glioblastoma: a review on the impact of treatment modalities
P. D. Delgado-Lopez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models
Soon Young Park et al.
MOLECULAR CANCER THERAPEUTICS (2016)
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A. Brandes et al.
NEURO-ONCOLOGY (2016)
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Brenda Auffinger et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
Brenda Auffinger et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Periostin is a novel therapeutic target that predicts and regulates glioma malignancy
Andrei M. Mikheev et al.
NEURO-ONCOLOGY (2015)
Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis
Yu-Jun Liu et al.
TUMOR BIOLOGY (2015)
Periostin is a new potential prognostic biomarker for glioma
Buxian Tian et al.
TUMOR BIOLOGY (2014)
The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients
Michelle Paff et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Heart failure entails significant changes in human nucleocytoplasmic transport gene expression
Maria Micaela Molina-Navarro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
RANBP17 is localized to the XY body of spermatocytes and interacts with SPEM1 on the manchette of elongating spermatids
Jianqiang Bao et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
HOXC6 and HOXC11 increase transcription of S100 beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells
Xiuru Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of two novel RanGTP-binding proteins belonging to the importin β superfamily
U Kutay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
